慢性乙型肝炎、慢性丙型肝炎或非酒精性脂肪性肝炎相关晚期纤维化与肝硬化中的线粒体应激
研究纳入146例未治疗的慢性乙型肝炎单感染患者,比较晚期纤维化或肝硬化(F3-F4)与无/轻中度纤维化(F0-F2)患者的线粒体改变,并与慢性丙型肝炎33例、非酒精性脂肪性肝炎12例及健康对照24例比较。F3-F4患者存在线粒体DNA氧化损伤、多个缺失及线粒体功能、动态相关改变,体外实验显示乙型肝炎病毒复制或HBx表达可致线粒体超氧化物增加、复合物I损伤,可被Mito-Tempo或iNOS抑制剂1400 W预防。
要点
- 慢性乙型肝炎F3-F4患者较F0-F2患者存在线粒体DNA链断裂和多个缺失。
- 慢性乙型肝炎、慢性丙型肝炎和非酒精性脂肪性肝炎相关晚期纤维化或肝硬化均可见线粒体功能与动态改变。
- 体外实验中乙型肝炎病毒复制或HBx表达增加线粒体超氧化物和过氧亚硝酸盐形成、复合物I损伤,可被Mito-Tempo或1400 W预防。
核心结论
- 慢性乙型肝炎和非酒精性脂肪性肝炎相关晚期纤维化或肝硬化中,线粒体氧化应激、线粒体DNA损伤及线粒体功能与动态改变具有重要作用。
- 线粒体可能成为阻止纤维化进展的药物研发靶点。
研究设计与样本
- 研究纳入146例未治疗的慢性乙型肝炎单感染患者,将晚期纤维化或肝硬化(F3-F4)患者与无/轻中度纤维化(F0-F2)患者比较。
- 慢性乙型肝炎患者进一步与慢性丙型肝炎患者(n=33)、非酒精性脂肪性肝炎患者(n=12)和健康对照(n=24)比较。
- 体外实验使用复制乙型肝炎病毒或瞬时表达乙型肝炎病毒X蛋白的HepG2细胞。
主要发现
- F3-F4患者较F0-F2患者检测到线粒体DNA氧化损伤,包括线粒体DNA链断裂,并鉴定出多个线粒体DNA缺失。
- 慢性乙型肝炎、慢性丙型肝炎和非酒精性脂肪性肝炎相关晚期纤维化或肝硬化患者中观察到线粒体功能、线粒体未折叠蛋白反应、生物发生、线粒体自噬及肝脏炎症的改变。
- 体外实验中,复制乙型肝炎病毒或瞬时表达乙型肝炎病毒X蛋白的HepG2细胞出现线粒体超氧化物和过氧亚硝酸盐形成显著增加、线粒体DNA损伤、线粒体呼吸链复合物硝化及复合物I损伤。
- 线粒体DNA损伤和复合物I损伤可被超氧化物清除剂Mito-Tempo或诱导型一氧化氮合酶(iNOS)特异性抑制剂1400 W预防。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Hepatitis B virus (HBV) infection causes oxidative stress (OS) and alters mitochondria in experimental models. Our goal was to investigate whether HBV might alter liver mitochondria also in humans, and the resulting mitochondrial stress might account for the progression of fibrosis in chronic hepatitis B (CHB). APPROACH AND RESULTS: The study included 146 treatment-naïve CHB mono-infected patients. Patients with CHB and advanced fibrosis (AF) or cirrhosis (F3-F4) were compared to patients with no/mild-moderate fibrosis (F0-F2). Patients with CHB were further compared to patients with chronic hepatitis C (CHC; n = 33), nonalcoholic steatohepatatis (NASH; n = 12), and healthy controls ( n = 24). We detected oxidative damage to mitochondrial DNA (mtDNA), including mtDNA strand beaks, and identified multiple mtDNA deletions in patients with F3-F4 as compared to patients with F0-F2. Alterations in mitochondrial function, mitochondrial unfolded protein response, biogenesis, mitophagy, and liver inflammation were observed in patients with AF or cirrhosis associated with CHB, CHC, and NASH. In vitro , significant increases of the mitochondrial formation of superoxide and peroxynitrite as well as mtDNA damage, nitration of the mitochondrial respiratory chain complexes, and impairment of complex I occurred in HepG2 cells replicating HBV or transiently expressing hepatitits B virus X protein. mtDNA damage and complex I impairment were prevented with the superoxide-scavenging Mito-Tempo or with inducible nitric oxide synthase (iNOS)-specific inhibitor 1400 W. CONCLUSIONS: Our results emphasized the importance of mitochondrial OS, mtDNA damage, and associated alterations in mitochondrial function and dynamics in AF or cirrhosis in CHB and NASH. Mitochondria might be a target in drug development to stop fibrosis progression.
引用
- Loureiro D, Tout I, Narguet S, et al. Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis. Hepatology. 2022. PMID: 35971873. doi:10.1002/hep.32731
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。